Skip to content

Avanos Medical AVNS Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value at other companies

Belden logo
BeldenBDC
$1.13M-20.8%
Avanos Medical logo
Avanos MedicalAVNS
$0
CHE
ChemedCHE
$4.55M-57.6%
HTF
Heartflow, Inc. Common StockHTFL
$12.2M+1,009%
KEE
Keel Infrastructure Corp. Common StockKEEL
$5.26M+279%
McCormick & Company, Incorporated logo
McCormick & Company, IncorporatedMKC
$4.6M+39.4%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B-1.2%
Enterprise value$1.24B+3.0%
P/S1.6×-0.1×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.

The official record: Avanos Medical’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's share based compensation arrangement by share based payment award options exercises in period total intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
Avanos Medical (AVNS) reported share based compensation arrangement by share based payment award options exercises in period total intrinsic value of $0 in Q4 2025.
What is the long-term trend for Avanos Medical's share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
Over 4 years (2021 to 2025), Avanos Medical's share based compensation arrangement by share based payment award options exercises in period total intrinsic value has grown at a -100.0% compound annual growth rate (CAGR), from $1.6M to $0.
What does share based compensation arrangement by share based payment award options exercises in period total intrinsic value mean?
The total intrinsic value realized by employees upon the exercise of stock options during the reporting period. This represents the difference between the market price of the stock at the time of exercise and the exercise price, reflecting the actual economic benefit captured by employees.